Literature DB >> 20956723

A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes.

Manuel Zorzi1, Stefano Guzzinati, Donella Puliti, Eugenio Paci.   

Abstract

BACKGROUND: The estimation of breast cancer screening sensitivity is a major aim in the quality assessment of screening programmes. The proportional incidence method for the estimation of the sensitivity of breast cancer screening programmes is rarely used to estimate the underlying incidence rates.
METHODS: We present a method to estimate episode and programme sensitivity of screening programmes, based solely on cancers detected within screening cycles (excluding breast cancer cases at prevalent screening round) and on the number of incident cases in the total target population (steady state). The assumptions, strengths and limitations of the method are discussed. An example of calculation of episode and programme sensitivities is given, on the basis of the data from the IMPACT study, a large observational study of breast cancer screening programmes in Italy.
RESULTS: The programme sensitivity from the fifth year of screening onwards ranged between 41% and 48% of the total number of cases in the target population. At steady state episode sensitivity was 0.70, with a trend across age groups, with lowest values in women aged 50-54 years (0.52) and highest in those 65-69 (0.77).
CONCLUSIONS: The method is a very serviceable tool for estimating sensitivity in service screening programmes, and the results are comparable with those of other methods of estimation.

Entities:  

Mesh:

Year:  2010        PMID: 20956723     DOI: 10.1258/jms.2010.009060

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  3 in total

1.  Co-expression of Oct-4 and Nestin in human breast cancers.

Authors:  Caigang Liu; Xuezhao Cao; Yanjun Zhang; Hong Xu; Ruishan Zhang; Yunfei Wu; Ping Lu; Feng Jin
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

2.  Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.

Authors:  Jessica Chubak; Andrea N Burnett-Hartman; William E Barlow; Douglas A Corley; Jennifer M Croswell; Christine Neslund-Dudas; Anil Vachani; Michelle I Silver; Jasmin A Tiro; Aruna Kamineni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

3.  A simple way to measure the burden of interval cancers in breast cancer screening.

Authors:  Sune Bangsbøll Andersen; Sven Törnberg; Elsebeth Lynge; My Von Euler-Chelpin; Sisse Helle Njor
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.